Efficacy of topical antifungal agents in the treatment of dermatophytosis: An incomplete meta-analysis

JAMA Dermatology

Volumn 149, Issue 10, 2013, Pages 1243-1244

  Fedorowicz, Zbys ^a   Van Zuuren, Esther J ^b  

^a UK Cochrane Centre (Bahrain Branch)   (Bahrain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

DERMATOPHYTOSIS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; INTERVENTION STUDY; LANGUAGE; LETTER; META ANALYSIS (TOPIC); PORTUGAL; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RISK ASSESSMENT; SPAIN; SYSTEMATIC REVIEW (TOPIC);

ANTIFUNGAL AGENTS; DATA INTERPRETATION, STATISTICAL; DERMATOMYCOSES; HUMANS;

EID: 84885910941     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.5065     Document Type: Letter

References (5)

1. Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NLMC, Correr CJ. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149(3): 341-349.
2. Türp JC, Schulte JM, Antes G. Nearly half of dental randomized controlled trials published in German are not included in Medline. Eur J Oral Sci. 2002;110(6): 405-411.
3. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5, rating the quality of evidence - publication bias. J Clin Epidemiol. 2011;64(12): 1277-1282.
4. Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther. 2008;88(2): 156-175.
5. Herbison P, Hay-Smith J, GillespieWJ. Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol. 2006;59(12): 1249-1256.